Post-COVID-19 syndrome in a patient with VIH. Case report
Keywords:
COVID-19, VIH, síndrome post-COVID-19Abstract
Post-COVID-19 syndrome -19 is studied in the world, because it is a diagnosis that appears two years ago, related to a new disease. This case is presented with the objective to discover the evolution of a patient with VIH and a diagnosis of post-COVID-19 syndrome. A 30-year-old male patient, with personal history of seropositive to VIH is presented. He is confirmed by polymerase with inverse transcriptase chain reaction in real time which was positive to COVID-19. Some days after his discharge, he begins to complain of tiredness, fatigue, and sweating, joint pains, shortness of breath, palpitations and occasional insomnia. The clinical characteristics and the epidemiological history are very important for the diagnosis, infectious processes and other etiologies are discarded. The diagnosis of post-COVID-19 syndrome tends to be delayed. This syndrome affects life quality and job incorporation of patients.
Downloads
References
Ministerio de Salud Pública. Anuario estadístico de salud 2020[Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2020 [citado 31 Ago 2022]. Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020.pdf
ONUSIDA[Internet]. Ginebra: ONUSIDA; © 2022 Hoja informativa Últimas estadísticas sobre el estado de la epidemia de sida. [citado 31 Ago 2022]. Disponible en: https://www.unaids.org/es/resources/fact-sheet
Marañón-Cardonne T, Griñan-Semanat D, Landazuri-Llago S, Marañón-Reyes E. Investigaciones clínicas sobre COVID-19. Una breve panorámica. Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [citado 31 Ago 2022]; 10 (3): 9-13. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/910
Centers for Disease Control and Prevention[Internet].
Atlanta: Centers for Disease Control and Prevention; 2022. Post-COVID Conditions. [citado 31 Agio 2022] Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA [Internet]. 2020 [citado 31 Ago 2022];324(6):603-5. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2768351/
COVID-19 rapid guideline: managing the long-term effects of COVID-19[Internet]. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18. [citado 31 Ago 2022]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33555768/ PMID: 33555768
Dennis A, Wamil M, Kapur S, Alberts J, Badley AD, Anton G, et al. Multi-organ impairment in low-risk individuals with long COVID. Med Rxiv [Internet]. 2020 Oct[citado 31 Ago 2022]; 16. Disponible en: https://www.medrxiv.org/content/10.1101/2020.10.14.20212555v1.full-text
Islam MF, CotlerJ, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health & Behavior [Internet]. 2020 [citado 31 Ago 2022];8(2): 61-9. Disponible en: https://www.tandfonline.com/doi/epub/10.1080/21641846.2020.1778227?needAccess=true
Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol[Internet].2011[citado 31 Ago 2022];11: 37. Disponible en: https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-11-37
Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-JiménezJ, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect [Internet]. 2021 [citado 31 Ago 2022];82(3):378-83. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802523/
National Institute for Health Research (NIHR) [Internet]. London: NIHR; 2016-2022. Living with Covid-19. A dynamic rewiew of evidence around ongoing covid-19 symptoms (often called long Co-vid) [citado 31 Ago 2022]. Disponible en: https://evidence.nihr.ac.uk/themedreview/living-with-covid19/
Galván-Tejada CE, Herrera-García CF, Godina-González S, Villagrana-Bañuelos KE, Amaro JDL, Herrera-García K, et al. Persistence of COVID-19 Symptoms after Recovery in Mexican Population. Int J Environ Res Public Health [Internet]. 2020 [citado 31 Ago 2022];17(24):9367. Disponible en: https://www.mdpi.com/1660-4601/17/24/9367/htm
De Lorenzo R, Conte C, Lanzani C, Benedetti F, Roveri L, Mazza MG, et al. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoSOne [Internet]. 2020 [citado 31 Ago 2022];15(10):e0239570. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556454/
Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, Toresdahl BG, et al. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am [Internet]. 2020 [citado 31 Ago 2022];102(14):1197-1204. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508274/
National Institute for Health Research (NIHR) [Internet]. London: NIHR; 2016-2022. Living with COVID–second review. March 2021 [citado 31 Ago 2022]. Disponible en: https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review
Townsend L, Dowds J, O'Brien K, Sheill G, Dyer AH, O'Kelly B, et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc [Internet]. 2021 [citado 31 Ago 2022];18(6):997-1003. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456724/
Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, COVERSCAN study investigators, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open [Internet]. 2021 [citado 31 Ago 2022];11(3):e048391. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727683/
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet [Internet]. 2021 [citado 31 Ago 2022];397(10270):220-32. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620326568?via%3Dihub
Downloads
Published
How to Cite
Issue
Section
License
Medimay protects copyright from the very first moment the submission is made, but upon publication it assumes a Creative Commons 4.0 (cc-by-nc) license, which allows the use of the work to share (copy and redistribute the material in any medium or format) and adapt (remix, transform and build from the material) as long as exclusive mention is made of the publication in the journal as a primary source, prohibiting its commercialization. The author always retains his/her right.